Homepage / Investment / Cramer Remix: It’s not about sex appeal, it’s about timing
GoodRx, a service for finding bargains on prescription drugs, is in sale talks for up to $3 billion The 4 fastest-growing job skills of the next three to five years: LinkedIn Buffett, Bezos and Dimon's health-care pick is known as a thought leader, not a business leader Alexa goes to college: Northeastern is giving students Amazon Echo Dots Disney-Comcast bidding war for Fox will go up to $45 a share before Disney wins: media expert Tesla's alleged rogue employee is exactly what Congress is worried about with self-driving cars Former Citrix chief Mark Templeton takes over at cloud start-up DigitalOcean Apple makes a big push into kids' content with creators of Sesame Street A year later, what Uber has done to revamp its troubled image The United States just built the world's fastest supercomputer — here's what that means Instagram crosses 1 billion monthly active users, unveils long-form video Microsoft acquires Bonsai to help with its artificial intelligence push Stitch Fix shares pop on speculation of Oprah taking stake in the company The AT&T-Time Warner ruling is making the Murdoch family billions of dollars richer Here's why Google and Amazon probably will never be included in the Dow Chinese investment in the US drops 90% amid political pressure Tesla sues former employee for allegedly stealing gigabytes of data, making false claims to media Nasdaq CEO says ICOs are 'taking advantage' of retail investors JP Morgan is unleashing artificial intelligence on a business that moves $5 trillion for corporations every day This health tech start-up refused to take money from VC firms unless they had a female partner General Electric shareholders should rejoice at the Dow removal US existing home sales fall for second straight month Silicon Valley has an Achilles’ heel that threatens its supremacy in innovation Threatened by coalition partner, Merkel seeks to break migration deadlock China has an Iran oil lever over Trump and it's all playing out at OPEC meeting How tech companies conquered America's cities Nantucket home prices break record highs Oracle reduced visibility into its cloud business, and some analysts aren't happy Buffett, Bezos, Dimon appoint Dr. Atul Gawande as CEO of their newly formed health care company AMC will offer its own MoviePass-like subscription AT&T Advertising CEO: We need to buy more technology to make ads less obtrusive and more relevant Buy beaten-down Citi shares ahead of stress test results and earnings, Deutsche Bank says Disability applications plunge as the economy strengthens A ‘day of reckoning’ is coming for stocks. Here’s what could spark it, says market watcher Disney raises bid for Fox assets to $71.3 billion in cash and stock Morgan Stanley downgrades Starbucks due to its China sales growth stumble Trump wages trade conflicts during historically difficult time for the stock market A cruel summer for stocks is likely upon us, Federated's Phil Orlando warns OPEC set for a collision course over production policy ahead of landmark meeting Stocks making the biggest moves premarket: WGO, GE, FDX, ORCL, SBUX & more GE shares drop after the blue chip gets booted from the Dow, ending a 110-year run EU to hit $3.2 billion of US imports starting Friday in response to Trump's tariffs Mortgage applications jump 5.1% as interest rates settle Kroger, on a 'wild ride' in the last year, reports earnings this week. Here's how to play it Hopes are rising of a breakthrough in one of Africa's longest conflicts Bitcoin is 'not for me' but it's too 'arrogant' to say it won't have a future, Goldman Sachs CEO says High oil prices are a massive headache for India as economy gets 'pinched' The ECB has lost its independence in the wake of the debt crisis, a former member claims The ‘crypto sculpture’ and how hyped things have become Asian economies have a lot to lose in a US-China trade war CEO explains why his Australian company just announced 8,000 job cuts European stocks seen higher amid rising trade war fears; OPEC in focus White House says China's 'economic aggression' is a global threat The inspiration for tech titan Jack Ma's Alibaba was an unlikely politician Microsoft's Nadella: Trump administration policy separating children from families is 'abhorrent' A major cryptocurrency exchange says it was hacked and $30 million in coins was stolen Canada approves recreational use of marijuana Lapses at many levels of bank led to India's huge PNB fraud, internal report shows Australia's largest telco says it will cut 8,000 jobs over the next three years China-based hacking campaign is said to have breached satellite, defense companies Kim Jong Un and China's Xi discuss 'a new future,' North Korean media says Worst isn't over for General Electric, predicts ex-GE transportation CEO Asian shares set for mixed open after trade fears spook markets worldwide Cramer: Tesla's stock still has more upside—just use the right chart Cramer points to the trillion-dollar question about US-China trade: What about Apple? Elon Musk: If I can help kids at the border, I will SNAP CEO on Innovation and Imitation Oracle reports strong fourth quarter results and stock edges up Start-up that uses polymer science to make avocados last longer just scored a deal with Costco Here's a map of every Whole Foods where you'll get an Amazon Prime discount The CEO of agency giant IPG welcomes challengers to Facebook and Google: 'The more the merrier' Traders bet one soaring tech stock is about to lose steam Facebook takes another shot at grabbing social media stars from YouTube UK says it is happy with Rupert Murdoch's Sky News commitments related to bid for parent company Apple CEO Tim Cook says separating immigrant children at US border is 'inhumane' In the short history of Trump trade conflicts, it has paid to buy the market dip Danny Meyer stands by cashless push: 'We're unaware of any federal law' that requires accepting cash Express Scripts boots another online pharmacy — CareZone — from its network Home Depot and two other Dow stocks look ripe for a buy, says technician Snap shares plunge after analyst says users are less engaged White House's Navarro on China trade talks: No knowledge of Apple iPhone exemption Merkel, Macron agree on euro zone budget Walgreens and Humana are partnering to create senior health hubs Sarepta Therapeutics shares soar 50% on positive preliminary results for muscular dystrophy gene therapy Verizon pledges to stop some selling of phone-location data There's one Dow stock having a great day: Verizon Europe's IPO market heats up, and unicorns are getting in line Amazon wants a hand in all your deliveries, unveils last-step option for FedEx, UPS and private mail Soybean prices drop to two-year low on US-China trade war fears Cramer: US-China trade fight 'is not serious' right now; Trump has upper hand China has a limited number of weapons to use in a trade war with the US Laws governing medical marijuana could soon be relaxed in the UK The flip phone is about to make a big comeback as foldable screen nears reality Here is what a student could have made if they invested their 2014 summer earnings in FANG stocks VW names interim Audi boss, seeking to steady brand after its CEO's arrest Here’s the fundamental error in Trump’s trade strategy Chip stocks dive on trade war fears as industry gets a majority of its revenue from China New home construction booms to a near 11-year high in May A dangerous dot-com era phenomenon is back and it's going to inflict pain, Jim Paulsen warns Netflix gets a $500 price target, the highest on Wall Street

Investment

Cramer Remix: It’s not about sex appeal, it’s about timing

In a market hungry for spin-offs, CNBC’s Jim Cramer keeps an eye out for company break-ups that could prove to be lucrative for investors.

That’s why the “Mad Money” host caught sight of the “corporate divorce” between commodity chemical giant Huntsman and its recently spun-off entity, Venator Materials, which came public at $20 a share and has since reached $23.

Cramer thought Huntsman timed the spin-off very well. Venator took Huntsman’s titanium dioxide business just as demand in the titanium dioxide industry started to pick up again.

Plus, Venator has its hands in the recovering U.S. and European markets, and Cramer thinks Europe’s economic rebound will be strong and long-lasting.

“Venator Materials may not be the sexiest company ever, but … this spinoff came at the ideal moment, right when Venator’s core titanium dioxide business is experiencing a real renaissance,” Cramer said. “This story has a lot going for it, more than almost all the other spin-offs I’ve heard of, and unlike so much of the market, this is a cheap stock. I say the potential rewards dramatically outweigh the risks and Venator’s stock makes a ton of sense to buy in this wildly pro-spin-off market.”

In many ways, Cramer finds each trading day in the stock market to be very similar to a good fishing trip.

“This is like fishing, catching a 40-inch edible fish every day, each different from the day before,” Cramer said about the bounty of high-quality stocks.

Wednesday’s catch was the stock of McDonald’s. Shares of the fast-food chain broke out to all-time highs on practically no news, closing above $163 a share. Despite its lack of obvious upward drivers, Cramer said the inevitable analyst recommendations would likely help, not hurt.

Also swimming higher were shares of PayPal, which was upgraded to “buy” from “hold” by a major firm that argued worries about PayPal’s negotiations with eBay were overblown.

“This was a gift. I’m calling it a 40-pound striper caught surf casting,” Cramer joked.

But Cramer couldn’t help but wonder why such different situations are all working for these stocks, so he compiled a list of reasons for why the market is brimming with winners.

Since Sports Authority went bankrupt in 2016, Cramer has watched the sports retail and athletic wear cohort endure widespread weakness.

Just this year, Nike shares have inched up less than 1 percent, Columbia Sportswear’s shares are up about 4 percent and Under Armour shares have shed 43 percent of their value.

At first, the shortcomings were understandable, the “Mad Money” host said. Sports Authority, once the nation’s largest independent sporting goods retailer, was shuttering its stores, leaving fewer places for consumers to buy athletic products and an overflow of inventory.

“But now we’ve lapped the store closures and yet things just keep getting worse, something very few foresaw,” Cramer said.

Cramer argued that Sports Authority’s demise, which began with a leveraged buyout and ended with a botched restructuring program and crushing debt, cast a visible shadow on the sports retail industry.

When Wal-Mart announced a $20 billion share buyback and reiterated its bullish forecast for the fiscal year, you bet Cramer noticed.

“Wal-Mart’s being re-rated. This is an important term and I want everyone to understand it,” Cramer said. “This company is actually doing something that’s supposed to be theoretically impossible: it’s upping its spending on e-commerce; developing systems that will make Jet.com, one of its subsidiaries, a formidable competitor; it’s increasing its buyback by $20 billion; it’s paying people more while improving the store experience and it’s increasing earnings, plus possibly even beating Amazon.”

Even better, Wal-Mart shares are trading at only 19 times earnings, Cramer said, adding that his only regret is not pounding the table more on the big-box retailer’s story.

Finally, Cramer sat down with Clay Siegall, the co-founder, chairman and CEO of Seattle Genetics, on Wednesday to hear more about his company’s pipeline of cancer treatments.

Seattle Genetics currently has only one product on the market. Adcetris, its FDA-approved Hodgkin lymphoma treatment, has been performing strongly in studies performed on newly diagnosed cancer patients, a new development in the company’s ongoing research, Siegall said.

But that’s no longer the biotechnology company’s only treatment. In partnership with several other pharmaceuticals, Siegall said Seattle Genetics is developing treatments for bladder cancer and cervical cancer.

“Seattle Genetics is really changing from a one-drug company to a multi-product oncology company addressing unmet medical needs,” the CEO said.

In Cramer’s lightning round, he rattled off his take on some callers’ favorite stocks:

Energy Transfer Partners: “That is a horrible stock and I want you to sell it tomorrow morning. And I’m not kidding. And I mean it.”

PGT Innovations Inc.: “I like this as a housing play. I like it. It’s got a good Florida business. Look, Home Depot is the classic, but I think this is a good situation. Seems very cheap.”

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagramVine

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Source: Investment Cnbc
Cramer Remix: It’s not about sex appeal, it’s about timing

Comments are closed.